Background and aims: Urinary tract infections (UTIs) are relatively common infections in children. Findings on nuclear renal scans suggest that the vast majority of infants and young children with ...
Spero Therapeutics announced that the Food and Drug Administration (FDA) has granted Fast Track designation for SPR994 (tebipenem pivoxil hydrobromide) for the treatment of complicated urinary tract ...
"The five factors with the highest odds of developing APN included obstructive and reflux uropathy, presentation to an acute care facility, urinary retention, history of UTI, and renal comorbidities.
New French guidelines reshape care for urinary tract infections in men, dropping urine dipsticks, recognizing male cystitis, and clarifying antibiotic choices and treatment durations.
GSK has resubmitted its NDA to the FDA for tebipenem HBr, an oral carbapenem for complicated UTIs, backed by positive phase 3 ...
Spero Therapeutics announced that the Food and Drug Administration (FDA) has granted Fast Track designation for SPR994 (tebipenem pivoxil hydrobromide) for the treatment of complicated urinary tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback